The 5 analysts offering 12-month price forecasts for DarioHealth Corp have a median target of 8.00, with a high estimate of 13.00 and a low estimate of 4.10. The median estimate represents a +149.22% increase from the last price of 3.21.
The current consensus among 5 polled investment analysts is to Buy stock in DarioHealth Corp. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.46
Reporting Date Nov 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.